The Role of Anatomical and Molecular Profiling in the Individualization of Treatment for Patients with Metastatic Colorectal Cancer

View Activity

PROGRAM CHAIR

Jeffrey A. Meyerhardt, MD, MPH
Associate Professor of Medicine
Harvard Medical School
Clinical Director, Gastrointestinal Cancer
Dana-Farber Cancer Institute
Boston, Massachusetts

SPEAKER FACULTY

Stephen Leong, MD
Associate Professor
Division of Medical Oncology
University of Colorado Denver
School of Medicine
Division of Medical Oncology
Denver, CO

PROGRAM OVERVIEW

This online activity will cover the treatment and management of patients with metastatic colorectal cancer.

TARGET AUDIENCE

This activity is intended for US-based community oncologists who predominately treat patients with advanced or mCRC.

LEARNING OBJECTIVES

On completing the program, attendees should be able to:

  • Review the rationale for and role of VEGF- and EGFR-targeted agents in the treatment of mCRC
  • Describe how anatomical profiling and molecular testing for biomarkers can inform treatment selection for patients with mCRC
  • Apply clinical data and guideline recommendations to inform decisions about the use of VEGF- and EGFR-directed therapy in treatment regimens for patients with mCRC
  • Individualize treatment for patients with mCRC using VEGF- and EGFR-targeted agents based on patient-specific factors

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT

Med Learning Group designates this online activity for a maximum of 1.0 AMA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the online activity.

NURSING CREDIT INFORMATION

This program would be beneficial for nurses involved in the treatment and management of patients with advanced or mCRC.
CNE Credits: 1.0 ANCC Contact Hour.

CNE ACCREDITATION STATEMENT

Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Awarded 1.0 contact hour of continuing nursing education for RNs and APNs.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF CONFLICTS OF INTEREST

PROGRAM CHAIR
Jeffrey A. Meyerhardt, MD, MPH reports that he has served as a consultant for Ignyla, Array Pharmaceutical, and Cota.

FACULTY
Stephen Leong, MD reports that he has served on the advisory board/received honorarium from Lilly USA LLC and has conducted research for Bristol-Myers Squibb, Karyopharm Therapeutics, and Deciphera Pharmaceuticals, Inc.

CME Content Review
The content of this activity was independently peer reviewed.

The reviewer of this activity has nothing to disclose.

CNE Content Review
The content of this activity was independently peer reviewed.

The reviewer of this activity has nothing to disclose.

The staff, planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:
Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
Sharine Griggs, Program Manager for Med Learning Group, has nothing to disclose.
Marcello Morgan, MD, MPH, Director of Medical and Scientific Services for Med Learning Group has nothing to disclose.
Lauren Welch, MA, VP, Accreditation and Outcomes, has nothing to disclose.
Brianna Hanson, Accreditation and Outcomes Coordinator, has nothing to disclose.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
During the course of this lecture, the faculty may mention the use of medications for both FDA-approved and nonapproved indications.

METHOD OF PARTICIPATION

There are no fees for participating and receiving CME credit for this online activity. To receive CME/CNE credit participants must:

1. Read the CME/CNE information and faculty disclosures.
2. Participate in the online activity.
3. Submit the evaluation form online.

You will receive your certificate as a downloadable file.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are science-based.
This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact Med Learning Group at info@medlearninggroup.com

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at http://medlearninggroup.com/privacy-policy/

RELEASE DATE: January 16, 2020

EXPIRATION DATE: January 16, 2021

View Activity

Copyright © 2020 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.